Sustained migraine and headache day improvement with fremanezumab (TEV-48125)

Authors
Category Primary study
ConferenceHeadache
Year 2017
This article has no abstract
Epistemonikos ID: 49b10d4844943fec907083b8d8512a5a604badc2
First added on: Apr 29, 2026